Home Search

ovarian cancer - search results

If you're not happy with the results, please do another search

Viome, Helomics Partner on Personalized Ovarian Cancer Treatments

The two companies will study the link between ovarian cancer and the gut microbiome with the hopes of guiding personalized treatments
3d rendered ovarian cancer illustration.

Ovarian Cancer Prognosis Improved via AI

Researchers say tool is more accurate at predicting ovarian cancer prognosis than current methods and pinpoints more effective treatments

Detection of Ovarian Cancer Recurrence: Quality Control Routines using an Integrated Proteomics Approach

The webinar will focus on some of the current challenges facing researchers looking to improve biomarker discovery for ovarian cancer.
Source: Myriad Genetics

Myriad to Use BRACAnalysis CDx as Companion Diagnostic for Clovis’ Ovarian Cancer Treatment

Collaboration is intended to fulfill a post-approval regulatory commitment by Clovis to the FDA for Rubraca (rucaparib).
Source: iStock/© AlexRaths

Color Genomics Launches Benefits Program for Breast, Ovarian Cancer Risk Testing

Today Color Genomics unveiled the Benefits Program for Genetic Testing for Breast and Ovarian Cancer Risk, a first-of-its-kind initiative to offer this type of...

More Ovarian Cancer Detected if Biomarker Velocities Are Scrutinized

A single biomarker plus a fixed threshold may equal a missed diagnosis—actually, a great many missed diagnoses. But fixed thresholds aren’t inevitable. For example,...
3d rendered ovarian cancer illustration.

Machine Learning Aids Detection of Cancerous Ovarian Lesions

Researchers have used machine learning to leverage ultrasound features of ovarian lesions to train a new model that can recognize whether a lesion is benign or cancerous using reconstructed images taken from photoacoustic tomography.
T-Cells Attacking Cancer Cell

Time of Day May Be Important for Cancer Diagnosis and Treatment

Key biologic features of tumor progression are influenced by the circadian rhythm, which could be used to optimize timing of drug delivery and maximize safety and efficacy.
Man with Duchenne muscular dystrophy sitting in a motorized wheelchair using power controller with degenerated hands

Duchenne Muscular Dystrophy Gene Linked to Cancer

New research links the X-chromosome gene DMD, mutations in which cause Duchenne muscular dystrophy, to a range of different cancers.
Cervical Cancer Cell

New Data Shows How Germline Interacts with Somatic Mutations in Cancer

New data suggests specific germline-somatic associations can affect cancer development.


Inside Precision Medicine